Compelling evidence suggests that tau pathology, defined by the accumulation of hyperphosphorylated aggregated forms of tau, is strongly associated with neurodegeneration and cognitive impairment in AD [6,9]. The gene discussed is MAPT; the disease is Alzheimer disease.